BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 17963170)

  • 1. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in Korean patients with adult-onset Still's disease.
    Youm JY; Woo JH; Kim TH; Bae SC; Yoo DH
    Scand J Rheumatol; 2007; 36(5):390-3. PubMed ID: 17963170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Fcgamma receptor polymorphisms with adult onset Still's disease in Korea.
    Woo JH; Sung YK; Lee JS; Chung WT; Choe JY; Song GG; Yoo DH
    J Rheumatol; 2009 Feb; 36(2):347-50. PubMed ID: 19040302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional association of interleukin 18 gene -607 (C/A) promoter polymorphisms with disease course in Chinese patients with adult-onset Still's disease.
    Chen DY; Chen YM; Chen HH; Hsieh CW; Lin CC; Lan JL
    J Rheumatol; 2009 Oct; 36(10):2284-9. PubMed ID: 19684151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
    Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
    J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
    Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
    Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer.
    Singh H; Sachan R; Goel H; Mittal B
    BJOG; 2008 Apr; 115(5):633-8. PubMed ID: 18333945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between adult-onset Still's disease and interleukin-18 gene polymorphisms.
    Sugiura T; Kawaguchi Y; Harigai M; Terajima-Ichida H; Kitamura Y; Furuya T; Ichikawa N; Kotake S; Tanaka M; Hara M; Kamatani N
    Genes Immun; 2002 Nov; 3(7):394-9. PubMed ID: 12424620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the polymorphism of interleukin-1 gene and the susceptibility to essential hypertension].
    Li Y; Xu P; Zhang PA; Li XY; Huang CX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):491-3. PubMed ID: 15476179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians.
    Achyut BR; Srivastava A; Bhattacharya S; Mittal B
    Clin Chim Acta; 2007 Feb; 377(1-2):163-9. PubMed ID: 17069782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 gene cluster polymorphisms associated with periodontal disease in type 2 diabetes.
    López NJ; Valenzuela CY; Jara L
    J Periodontol; 2009 Oct; 80(10):1590-8. PubMed ID: 19792847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association of interleukin-1beta and receptor antagonist (IL-1Ra) gene polymorphism with allograft function in renal transplant patients.
    Manchanda PK; Bid HK; Kumar A; Mittal RD
    Transpl Immunol; 2006 Apr; 15(4):289-96. PubMed ID: 16635751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined polymorphism analysis of glutathione S-transferase M1/G1 and interleukin-1B (IL-1B)/interleukin 1-receptor antagonist (IL-1RN) and gastric cancer risk in an Omani Arab Population.
    Al-Moundhri MS; Alkindy M; Al-Nabhani M; Al-Bahrani B; Burney IA; Al-Habsi H; Ganguly SS; Tanira M
    J Clin Gastroenterol; 2009 Feb; 43(2):152-6. PubMed ID: 18779738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population.
    Vishnoi M; Pandey SN; Choudhuri G; Mittal B
    Cancer Genet Cytogenet; 2008 Oct; 186(2):63-8. PubMed ID: 18940468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure.
    Buraczynska M; Ksiazek P; Kubit P; Zaluska W
    Cytokine; 2006 Nov; 36(3-4):167-72. PubMed ID: 17224277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationships among interleukin-1beta, interleukin-1 receptor antagonist gene polymorphism and susceptibility to gastric cancer].
    Li K; Yang J; Chen ZR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Nov; 41(6):1039-43. PubMed ID: 21265111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes.
    Cvetkovic JT; Wallberg-Jonsson S; Stegmayr B; Rantapaa-Dahlqvist S; Lefvert AK
    J Rheumatol; 2002 Feb; 29(2):212-9. PubMed ID: 11838837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The distribution of gene polymorphisms in the intron 2 and exon 2 of interleukin-1 receptor antagonist and their correlation with the serum lipoprotein level].
    Xu P; Li Y; Zhang PA; Li XY; Li GS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):522-6. PubMed ID: 15231136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
    Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
    Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study.
    Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
    Hum Immunol; 2008 Mar; 69(3):179-86. PubMed ID: 18396210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is interleukin-1 genotyping useful for the clinical management of patients with atrophic body gastritis?
    Lahner E; Corleto VD; D'Ambra G; Di Giulio E; Delle Fave G; Annibale B
    Aliment Pharmacol Ther; 2008 Feb; 27(4):355-65. PubMed ID: 18047563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.